These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21603983)

  • 21. Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
    Culver JO; Brinkerhoff CD; Clague J; Yang K; Singh KE; Sand SR; Weitzel JN
    Clin Genet; 2013 Nov; 84(5):464-72. PubMed ID: 23323793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.
    Tercyak KP; Peshkin BN; Streisand R; Lerman C
    Psychooncology; 2001; 10(4):336-46. PubMed ID: 11462232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
    Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
    J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of Norwegian Female BRCA1 and BRCA2 Mutation-Carrying Participants in Educational Support Groups: a Qualitative Study.
    Myklebust M; Gjengedal E; Strømsvik N
    J Genet Couns; 2016 Dec; 25(6):1198-1206. PubMed ID: 27091466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
    Sermijn E; Goelen G; Teugels E; Kaufman L; Bonduelle M; Neyns B; Poppe B; De Paepe A; De Grève J
    J Med Genet; 2004 Mar; 41(3):e23. PubMed ID: 14985394
    [No Abstract]   [Full Text] [Related]  

  • 26. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
    Ormondroyd E; Moynihan C; Watson M; Foster C; Davolls S; Ardern-Jones A; Eeles R
    J Genet Couns; 2007 Aug; 16(4):527-38. PubMed ID: 17492498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
    Bellcross CA; Leadbetter S; Alford SH; Peipins LA
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):728-35. PubMed ID: 23371291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
    Tercyak KP; Demarco TA; Mars BD; Peshkin BN
    Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with an individuals' decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?
    Caruso A; Vigna C; Bigazzi V; Leone C; Maggi G; Martayan A; Sega FM; Cognetti F; Savarese A
    Fam Cancer; 2011 Sep; 10(3):581-9. PubMed ID: 21604195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing.
    McKinnon W; Naud S; Ashikaga T; Colletti R; Wood M
    J Genet Couns; 2007 Aug; 16(4):433-56. PubMed ID: 17594133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population.
    Negura L; Uhrhammer N; Negura A; Artenie V; Carasevici E; Bignon YJ
    Fam Cancer; 2010 Dec; 9(4):519-23. PubMed ID: 20567915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration of Male Attitudes on Partnerships and Sexuality with Female BRCA1/2 Mutation Carriers.
    Mauer C; Spencer S; Dungan J; Hurley K
    J Genet Couns; 2016 Apr; 25(2):290-7. PubMed ID: 26250348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery.
    Shapira R; Turbitt E; Erby LH; Biesecker BB; Klein WMP; Hooker GW
    Fam Cancer; 2018 Oct; 17(4):485-493. PubMed ID: 29209897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cultural aspects of healthy BRCA carriers from two ethnocultural groups.
    Navarro de Souza A; Groleau D; Loiselle CG; Foulkes WD; Wong N
    Qual Health Res; 2014 May; 24(5):665-81. PubMed ID: 24692182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics.
    Zuradelli M; Peissel B; Manoukian S; Zaffaroni D; Barile M; Pensotti V; Cavallari U; Masci G; Mariette F; Benski AC; Santoro A; Radice P
    Breast Cancer Res Treat; 2010 Nov; 124(1):251-8. PubMed ID: 20373018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
    Eccleston A; Bentley A; Dyer M; Strydom A; Vereecken W; George A; Rahman N
    Value Health; 2017 Apr; 20(4):567-576. PubMed ID: 28407998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management updates for women with a BRCA1 or BRCA2 mutation.
    Nusbaum R; Isaacs C
    Mol Diagn Ther; 2007; 11(3):133-44. PubMed ID: 17570734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychological and familial aspects of the familial breast and ovarian cancer genetic counseling process].
    Flugelman A; Rennert G; Eidelman S
    Harefuah; 2014 Jan; 153(1):22-6, 65. PubMed ID: 24605403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
    Gabaldó Barrios X; Sarabia Meseguer MD; Marín Vera M; Sánchez Bermúdez AI; Macías Cerrolaza JA; Sánchez Henarejos P; Zafra Poves M; García Hernández MR; Cuevas Tortosa E; Aliaga Baño Á; Castillo Guardiola V; Martínez Hernández P; Tovar Zapata I; Martínez Barba E; Ayala de la Peña F; Alonso Romero JL; Noguera Velasco JA; Ruiz Espejo F
    Fam Cancer; 2017 Oct; 16(4):477-489. PubMed ID: 28477318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing for BRCA1 and BRCA2 in the Province of Ontario.
    Finch A; Wang M; Fine A; Atri L; Khalouei S; Pupavac M; Rosen B; Eisen A; Elser C; Charames G; Metcalfe K; Chang MC; Narod SA; Lerner-Ellis J
    Clin Genet; 2016 Mar; 89(3):304-11. PubMed ID: 26219728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.